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SURGICAL MANAGEMENT 
OF INFECTIVE 
ENDOCAROITIS ASSOCIATED 
WITH CEREBRAL 
COMPLICATIONS 
Multi-center etrospective 
study in Japan 
To establish guidelines for the surgical treatment of patients with infective 
endocarditis who have cercbrovascular complications, we conducted a
detailed retrospective study of 181 of 244 patients with cerebral complica- 
tions among 2523 surgical cases of infective endocarditis of the Japanese 
Association of Thoracic Surgery. The results showed that 9.7% of all 
patients with infective ndocarditis had associated cerebral complications: 
108 (44.3%) had active native valve endocarditis, 96 (39.3%) had healed 
native valve endocarditis, and 40 (16.4%) had prosthetic valve endocarditis. 
The hospital mortality of the patients with cerebral complications was 
11.0% in the group as a whole: 13.9% in active native valve endocarditis, 
3.1% in healed native valve endocarditis, and 37.5% in prosthetic valve 
endocarditis. Diseased valves included the following: aortic valve in 55.5%, 
mitral valve in 49.8%, tricuspid valve in 1.3%, and pulmonary valve in 1.3%. 
In 181 patients with cerebral complications, organisms were detected as 
follows: gram-positive cocci in 133 (73.5% [Streptococcus in 85, Staphylococ- 
cus in 32]), gram-negative in 18 (9.9%), fungus in 11 (6.1%), and unknown 
in 19 (10.5%). Types of cerebral complications included cerebral infarction 
in 64.6%, cerebral bleeding in 31.5%, cerebral abscess in 2.8%, and 
meningitis in 1.1%. Hospital mortality rate and an exacerbation rate of 
cerebral complications, including related death, according to the interval 
from onset of cerebral infarction to cardiac surgery, were as follows: 66.3% 
and 45.5% within 24 hours, 31.3% and 43.8% between 2 and 7 days, 16.7% 
and 16.7% between 8and 14 days, 10.0% and 10.0% between 15 and 21 days, 
26.3% and 10.5% between 22 and 28 days, and 7.0% and 2.3% over 4 weeks 
later, respectively. A significant correlation existed between the interval and 
the exacerbation of cerebral complications (tied p = 0.008). Preoperative 
risk factors affecting exacerbation of cerebral complications were as 
follows: (1) severity of cerebral complication (p = 0.006), (2) intervals 
(p = 0.012), and (3) uncontrolled congestive heart failure as indications 
for cardiac surgery (p = 0.014). One patient underwent a cardiac opera- 
tion within 24 hours of the onset of cerebral hemorrhage and died of 
cerebral damage. No exacerbations occurred in 10 patients who underwent 
their operation between 2 and 28 days. Nevertheless, exacerbations oc- 
curred in 19.0% of patients whose operation was done more than 4 weeks 
later. These data suggest that cardiac operations can bedone safely 4 weeks 
after cerebral infarction, and if the delay is more than 2 weeks, the 
Kiyoyuki Eishi, MD, Kouhei Kawazoe, MD, Yoshihiro Kuriyama, MD, 
Yoshitsugu Kitoh, MD, Yasunaru Kawashima, MD, and Teruo Omae, MD, 
Osaka, Japan, for the 174 centers of the Japanese Association of Thoracic 
Surgery 
From the Division of Cardiovascular Surgery, Division f Neu- 
rology, National Cardiovascular Center of Japan, Osaka, 
Japan. Supported inpart by a grant for research on cardio- 
vascular diseases from the Ministry of Health and Welfare, 
Japan. 
Received for publication Dec. 23, 1994. 
Accepted for publication April 19, 1995. 
Address for reprints: Kiyoyuki Eishi, MD, Division of Cardiovas- 
cular Surgery, National Cardiovascular Center of Japan, 5-7-1 
Fujishiro-dai, Suita, Osaka 565, Japan. 
J THORaC CARDIOVASC SURG 1995;110:1745-55 
Copyright © 1995 by Mosby-Year Book, Inc. 
0022-5223/95 $ .00 + 0 12/1/65888 
1745 
1746 Eishi et aL 
The Journal of Thoracic and 
Cardiovascular Surgery 
December 1995 
exacerbation rate will be around 10%. The risk of progression of cerebral 
damage is still significant 15 days and even 4 weeks after cerebral 
hemorrhage. (J Thorac Cardiovasc Surg 1995;110:1745-55) 
T he best means of treating patients with infective endocarditis who have various complications 
such as severe congestive heart failure, intramyocar- 
dial abscesses, sepsis, major embolization, or cere- 
bral aneurysm is the subject of controversy. In the 
past decade, early surgical treatment has been rec- 
ommended even during the active stage before 
progression of the lesions. 1-3 In patients with cere- 
brovascular complications, however, a surgical ap- 
proach to the cardiac lesion still involves several 
unsolved problems. 4"11 A major concern is the tim- 
ing of cardiac surgery in these patients, because 
cardiopulmonary b pass with unusual hypotension 
and total heparinization would amplify the cerebral 
ischemic damage and hemorrhage. 8 Several groups, 
ours included, have tried to clarify the safety period 
between the cerebrovascular event and he cardiac 
operation, instead of limiting the number of patients 
with cerebral complications in each group, s' 8-10 To 
establish the surgical treatment of patients with 
infective ndocarditis associated with cerebrovascu- 
lar complications, we conducted a detailed, retro- 
spective analysis of 181 of 244 patients with cerebral 
complications among 2523 surgical cases of infective 
endocarditis of the Japanese Association of Tho- 
racic Surgery (JATS). 
Patients and methods 
We sent a questionnaire to 600 centers belonging to the 
JATS and received replies from 261 centers, including 174 
departments with 2523 patients having cardiac operations 
for infective endocarditis. A total of 244 patients had 
associated cerebral complications, and 181 of them were 
analyzed in detail. The questionnaire consisted of two 
parts: (1) Each center was asked for a summary of the 
number and outcome of patients with infective endocar- 
ditis according to the types of infective endocarditis 1 
(active/healed and native valve/prosthetic valve) and the 
presence of cerebral complications; (2) the other portion 
inquired about each patient with cerebral complications, 
asking for details such as age, gender, atrial fibrillation, 
anticoagulant therapy, diseased valve, organism, effective- 
ness of antimicrobial therapy, reason for early cardiac 
operation, interval between the onset of symptoms and 
the cardiac operation, type of cerebral complication, 
cerebral aneurysm, prior cerebral surgery, severity, influ- 
ence of operation on cerebral damage, and outcome. 
Analyses and statistics, The difference in mortality 
between the group without cerebral complications and the 
group with cerebral complications was tested for signifi- 
cance by X 2 analysis. A diseased valve and an organism 
were summarized as characteristics of the patients having 
associated cerebral complications. The type and timing of 
cerebral disease were documented. To study the influence 
of cardiac surgery on preoperative c rebral complications, 
we analyzed the interval between the onset of cerebral 
complications and performance of the cardiac operation, 
as well as other preoperative ariables. The effectiveness 
of antimicrobial therapy was ranked in three grades (1 = 
ineffective, 2 = effective, and 3 = well controlled). Also, 
the severity of cerebral complications was ranked (1 = 
mild, 2 = moderate, and 3 = severe). Indications for early 
cardiac surgery included ineffectiveness of antimicrobial 
therapy, vegetations, and uncontrolled congestive heart 
failure. Cerebral angiographic examination was done in 
58.8% of the patients with cerebral hemorrhage. A corre- 
lation between the interval and the xacerbation f cere- 
bral complications was evaluated by means of the Spear- 
man rank correlation coefficient. The intervals were then 
classified in several groups, and a variability between the 
groups for the exacerbation was estimated by Scheffe's F 
procedure for post-hoe comparisons, according to the 
Kruskal-Wallis test. To analyze the risk factors affecting 
exacerbation f cerebral complications, we expressed pre- 
operative variables as mean _+ standard error. The differ- 
ence between the groups with and without exacerbation 
was tested for significance by the unpaired t test, and 
incidence was expressed as percentage ofpatients having 
the variable compared with the entire group of patients 
and then compared by ~ analysis. Moreover, all variables 
and incidence (transformed to continuous variables) were 
estimated by stepwise regression analysis. Statistical sig- 
nificance was accepted at a p level of <0.05. These 
analyses were done with the Stat View system (Abacus 
Concepts, Inc., Berkeley, Calif.). 
Results 
Summary of all patients with infective endocar- 
ditis. In total, 2523 patients having infective endo- 
carditis were treated surgically in 174 centers of 
JATS. Of all the patients, 893 (35.4%) had active 
native valve endocarditis, 1317 (52.2%) had healed 
native valve endocarditis, and 315 (12.5%) had 
prosthetic valve endocarditis. Operative mortality 
rate was 13.5% in those with active endocarditis, 
4.0% in those with healed endocarditis, and 33.3% 
in those with prosthetic valve endocarditis. On the 
other hand, 244 patients, 9.7% of all patients with 
infective ndocarditis, had associated cerebral com- 
plications. A total of 1080 (44.3%) had active endo- 
carditis, 96 (39.3%) had healed endocarditis, and 40 
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Table I. Summary of 2523 patients with infective endocarditis 
Without cerebral With cerebral 
complications complications Total 
No. of No. of No. of 
patients % HD patients % liD patients % HD 
ANVE 784 13.4 108 13.9 893 13.5 
HNVE 1220 4.1 96 3.1 1317 4.0 
PVE 275 32.7 4._.Q0 37.5 315 33.3 
Total 2279 10.8 244 13.5 2523 11.0 
HD, Hospital death; ANVE, active native alve ndocarditis; HNVE, healed native alve ndocarditis; PVE, prosthetic valve ndocarditis. 
Table II. Diseased valve in 244 patients 
No. % 
Aortic 126 55.5 
Mitral 113 49.8 
Tricuspid 3 1.3 
Pulmonary 3 1.3 
(16.4%) had prosthetic valve endocarditis. The mor- 
tality rates of the patients with cerebral complica- 
tions were 13.9% (active endocarditis), 3.1% 
(healed endocarditis), and 37.5% (prosthetic valve 
endocarditis). No differences in mortality were de- 
tected between the group without cerebral compli- 
cations and 1:he group with cerebral complications 
(Table I). 
Characteristics of patients having cerebral com- 
plications. Diseased valves in 244 patients having 
cerebral complications included the following: aor- 
tic valve, 126 (55.5%); mitral valve, 113 (49.8%); 
tricuspid valve, 3 (1.3%), and pulmonary valve, 3 
(1.3%) (Table II). In 181 patients of 244 having 
infective endocarditis with cerebral complications, 
organisms were detected as follows: gram-positive 
cocci in 133 (73.5% [Streptococcus in 85, Staphylo- 
coccus in 32]), gram-negative in 18 (9.9%) [Entero- 
coccus in 5, Escherichia coli in 3], fungus in 11 
(6.1%) [Candida in 8], and unknown in 19 (10.5%) 
(Table III). 
Cerebrovascular disease as the complication in 
patients with infective endocarditis. Details of ce- 
rebrovascular disease were analyzed in 181 pa- 
tients of 244 who had infective endocarditis with 
cerebral complications. The types of cerebral 
complication were as follows: cerebral infarction 
in 117 (64.6%), cerebral bleeding in 57 (31.5%), 
cerebral abscess in 5 (2.8%), and meningiti s in 2 
(1.1%). Cerebral infarction occurred before the 
operation in 112, during the operation in 2, and 
after the operation in 3. Hospital mortality rates 
Table IlL Organism in 181 patients 
No. % 
Gram positive 133 73.5 
Streptococcus 85 63.9 
Staphylococcus 32 24.1 
Others 16 12.0 
Gram negative 18 9.9 
Enterococcus 5 27.8 
Escherichia coli 3 16.7 
Others 10 55.6 
Fungus 11 6.1 
Candida 8 72.7 
Others 3 27.3 
Unknown 19 10.5 
were 21.4% in patients with preoperative onset, 
100% in those with onset during the operation, 
and 33.3% in those with postoperative onset. 
Cerebral bleeding occurred before the operation 
in 34, during the operation in 8, and after the 
operation in 15. Hospital mortality rates were 
17.6% in patients with preoperative onset, 50.0% 
in those with perioperative onset, and 73.3% in 
those with postoperative onset. 
Influence of cardiac surgery on preoperative ce- 
rebral infarction. In 11 patients, the cardiac oper- 
ation was performed within 24 hours after the onset 
of cerebral infarction (mortality rate 66.3%) (Figs. 1 
and 2). The operation was performed between 2 and 
7 days later in 16 patients (mortality rate 31.3%), 
between 8 and 14 days later in 12 patients (mortality 
rate 16.7%), between 15 and 21 days later in 10 
patients (mortality rate 10.0%), between 22 and 28 
days later in 19 patients (mortality rate 26.3%), and 
more than 4 weeks later in 43 patients (mortality 
rate 7.0%). The rates of exacerbation of cerebral 
complications, including related eath, were as fol- 
lows: 45.5% in patients who were operated on within 
24 hours, 43.8% in those operated on within 2 to 7 
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Fig. 1. Computed tomographic s ans of a patient with right middle cerebral artery infarction resulting 
from infective endocarditis. This patient underwent a Bentall-type operation for graft infection on the 
same day, resulting in massive brain swelling, and died 3 days later. Top row, Preoperative computed 
tomographic s ans; bottom row, postoperative scans. 
days, 16.7% for those operated on within 8 to 
14 days, 10.0% for those operated on within 15 to 21 
days, 10.5% for those operated on within 22 to 
28 days, and 2.3% for those operated on more than 
4 weeks later (Fig. 3). A significant correlation 
existed between the interval and the exacerbation of
cerebral complications by the Spearman rank corre- 
lation coefficient (tied p = 0.008). When the inter- 
vals were classified in three groups (within 7 days, 8 
to 14 days, and 15 to 28 days), a significant differ- 
ence for the exacerbation was confirmed by post-hoc 
comparisons (p = 0.022) between the group within 7 
days and the group treated at 15 to 28 days (Fig. 4). 
Preoperative risk factors at~ecting exacerbation of 
cerebral complications were analyzed statistically. 
The significant variables were severity of cerebral 
complication (p = 0.006), intervals (p -- 0.012), and 
uncontrolled congestive heart failure as an indica- 
tion for cardiac surgery (p = 0.014) (Table IV). The 
rate of ineffectiveness of antimicrobial therapy was 
two times greater in the group with exacerbation 
than in the group without exacerbation, although 
the difference was not verified statistically. 
Influence of cardiac surgery on preoperative ce- 
rebral hemorrhage. One patient underwent a car- 
diac operation within 24 hours after the onset of 
cerebral hemorrhage and died of cerebral damage. 
In another patient the cardiac operation was per- 
formed successfully 5 days later, with prior surgical 
treatment for cerebral aneurysm. In five patients the 
cardiac operation was performed between 15 and 21 
days later (mortality rate 20.0%) (Fig. 5). The 
operation was done between 22and 28 days later in 
six patients with no mortality and more than 4 weeks 
later in 21 patients (mortality rate 19.0%). No 
exacerbation of cerebral complications occurred in 
patients who underwent heir cardiac operation 
between 2 and 28 days. Nevertheless, exacerbations 
did occur, at a rate of 19.0%, in patients who were 
operated on more than 4 weeks later (Figs. 6 and 7). 
The group having exacerbations of symptoms con- 
tained only five patients, and there was no correla- 
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Fig. 3. Exacerbation rate of cerebral damage including death related to cerebral injury according to the 
intervals from the onset of cerebral infarction (CI) until the cardiac operation. 
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Fig. 4. Correlation between the interval from the onset of cerebral infarction (CI) until the cardiac 
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groups, a significant difference in exacerbations was confirmed by post-hoc omparisons between the group 
operated on within 7 days and the group operated on within 15 to 28 days. ns, Not significant. 
tion between the interval and the exacerbation of 
cerebral complications. 
All of the patients with exacerbation and 76.5% 
without exacerbation had cerebral arterial aneurysm 
before the operation, although acerebral angiographic 
examination was done in 58.8% of the patients with 
cerebral hemorrhage. No one with exacerbation had 
received surgical treatment for cerebral aneurysm be- 
fore the cardiac operation, whereas 27.6% without 
exacerbation had undergone an operation for cerebral 
disease. The variable influencing exacerbation, accord- 
ing to stepwise regression analysis (p = 0.013), was 
atrial fibrillation (Table V). 
Discussion 
This study consisted of a questionnaire to the 
centers belonging to the JATS. The 181 patients 
gleaned from 244 patients with cerebral complica- 
tions undergoing surgical treatment for infective 
endocarditis were able to be analyzed in detail. 
Several groups have tried to assess the effect of the 
timing of surgical therapy on patients with recent 
neurologic injuries, s' 8-10 However, because of the 
limited number of cases, the appropriate timing of 
surgical intervention has not been addressed ade- 
quately. This study was based on a sufficient number 
for discussion of the effect of cardiac operations on 
patients with cerebral complications. 
Characteristics of patients with cerebral compli- 
cations. It has been reported that 20% to 30% of 
patients with infective endocarditis may have cere- 
brovascular complications. 6' 8, 12-17 In this review of 
2523 surgical cases of infective ndocarditis, 9.7% of 
the total (12.1% of patients having active native 
valve endocarditis, 7.3% of those having healed 
native valve endocarditis, and 12.7% of those having 
prosthetic valve endocarditis) had associated cere- 
bral complications. Cerebral ischemia was present in 
64.6% and hemorrhage in 31.5%. 6, is Staphylococcus 
aureus was the most virulent organism involved in 
the central nervous system. 1'6,7, 18-20 However, in 
this study of cerebral complications, Streptococcus 
was the most common organism followed by Staph- 
ylococcus. This trend mirrors findings in the whole 
population of patients with infective endocarditis. 1 
In 42% of the patients with cerebral complications, 
antibiotics were ineffective. 
Mortality of cardiac surgery in patients having 
infective endocarditis with cerebral complications 
compared with that of patients without cerebral 
complications. The operative outcome would be 
influenced by the organism, the intensity of cardiac 
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Fig. ~. Computed tomographic scans of a patient with cerebral hemorrhage resulting from infective 
endocarditis. This patient underwent mitral valve rereplacement 15 days after cerebral hemorrhage without 
any complications. Left, Preoperative computed tomographic scan; right, postoperative scan. 
Table IV. Analysis of risk factors affecting exacerbation of cerebral complications in 68 patients who had 
cerebral infarction within 4 weeks 
Exacerbation 
With (n = 17) Without (n = 51) Significance 
Cont inuous variables (mean ± SE) 
Age (yr) 45.5 _+ 
Effect of AM (1/2/3) 1.6 ± 
Severity of CC (1/2/3) 2.2 ± 
Interval  (days) 7.9 ± 
Nomina l  var iables (%):~ 
Gender  (male) 47.i  
Atria][ f ibri l lation 17.6 
Ant icoagulant  therapy 35.3 
Aort ic  lesion 70.6 
Mitral  lesion 41.1 
Ineffectiveness of AM 41,2 
Vegel;ation 70.6 
Congest ive heart  fai lure 76.5 
3.7 40.4 -+ 2.1 p = 0.237 
0.2 2.0 -+ 0.1 p = 0.126 
0.2 1.7 +- 0.1 p = 0.006~" 
2.2 15.1 ± 1.4 p = 0.012 
52.9 p = 0.674 
25.5 p = 0.509 
23.5 p = 0.341 
51.0 p = 0.159 
62.7 p = 0.119 
20.0 p = 0.083 
84.0 p = 0.227 
42.O p = 0.014 
SE, standard error; AM, antimicrobial therapy; CC, cerebral complication. Underlining showed the significant factor by t or X z test. 
*p Values for continuous variables were determined by the unpaired t test. 
?Significant (p = 0.017) by stepwise regression analysis. 
~p Values for nominal variables were determined by the )(2 test. 
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Table V. Analysis of risk factors affecting exacerbation fcerebral complications in 34 patients who ad 
cerebral hemorrhage preoperatively 
Exacerbation 
With (n = 5) Without (n = 29) Significance 
Continuous variables (mean + SE)* 
Age (yr) 37.6 _+ 3.4 
Effect of AM (1/2/3) 2.0 _+ 0.4 
Severity of CC (1/2/3) 2.4 _+ 0.2 
Interval (days) 178 _+ 111 
Nominal variables (%)? 
Gender (male) 60.0 
Atrial fibrillation 40.0 
Anticoagulant therapy 20.0 
Aortic lesion 80.0 
Mitral lesion 20.0 
Ineffectiveness of AM 40.0 
Vegetation 40.0 
Congestive heart failure 60.0 
Cerebral aneurysm 100 
Cerebral operation 0.0 
38.1 -+ 3.2 p = 0.953 
2.1 -+ 0.1 p = 0.827 
2.0 + 0.1 p = 0.296 
80.5 -+ 25 p = 0.196 
65.5 p = 0.812 
13.8 p = 0.156:~ 
27.6 p = 0.723 
58.6 p = 0.364 
48.3 p = 0.110 
20.7 p = 0.347 
58.6 p = 0.440 
65.6 p = 0.812 
76.5 p = 0.348 
27.6 p = 0.179 
SE, Standard error; AM, antibiotics; CC, cerebral complication. 
*p Values for continuous variables were determined by the unpaired t test. 
tp Values for nominal variables were determined by the ~ test. 
~:Significant (p = 0.013) by stepwise regression analysis. 
dysfunction, the presence of annular abscess, and so 
forth. Irrespective of these factors, the mortality rate 
in patients with cerebral complications was no 
higher than that in patients without cerebral com- 
plications in this study (13.5% versus 11.0%). Also, 
the mortality rate in the patients with cerebral 
hemorrhage was no higher than that in patients with 
cerebral infarction (20.0% versus 20.7%). Pruitt and 
associates 21reported that the mortality rate for 84 
patients with neurologic omplications was 58%, in 
contrast o the 20% mortality rate among the 134 
patients without neurologic involvement. Operative 
mortality for early valve replacement ranges from 
10% to 37%. 2:, 7, 20, 22-26 The preoperative condition 
of the patients with cerebral complications, espe- 
cially of those requiring early operation, would be 
more severe. ,Our results showed that preoperative 
cerebral complications caused a substantial number 
of deaths. It is clear that the timing of the cardiac 
operation affects the outcome in patients with cere- 
bral infarction. 
Influence of cardiac surgery on preoperative ce- 
rebral infarction. The major purpose of this study is 
to clarify how long to wait before performing a 
cardiac operation after the onset of cerebral com- 
plications in patients in whom early cardiac repair 
would be advisable. In 43.8% of the patients requir- 
ing a cardiac operation within 7 days after cerebral 
infarction, cerebral damage was exacerbated. The 
exacerbation rate decreased gradually with the tim- 
ing of the operation and, in the group operated on 
after 28 days, it was 2.3%. 
According to these data, a cardiac operation can 
be done safely after 4 weeks; after a delay of more 
than 2 weeks, the exacerbation rate will be around 
10%. If the natural history of the patient receiving 
medication is expected to be very bad, surgical 
repair might be appropriate ven in a week. More- 
over, if the patient requires an early operation 
because of uncontrolled heart failure or if the 
preoperative c rebral infarction is severe, the risk of 
surgical treatment would be higher than expected 
according to timing of the operation. Ineffectiveness 
of antimicrobial therapy may affect cerebral dam- 
age, although such an effect was not verified statis- 
tically. 
Influence of cardiac surgery on preoperative ce- 
rebral hemorrhage. The number of patients who 
underwent a cardiac operation within 4 weeks after 
cerebral infarction was large, whereas the number 
having the operation within 4 weeks after hemor- 
rhage might be too small (13 patients) to allow us to 
evaluate the influence of the passage of time before 
heart surgery. However, heart surgery within 24 
hours after cerebral hemorrhage has a high risk of 
causing fatal cerebral damage. Although no one of 
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the 11 patients who underwent cardiac surgery 
between 15 days and 28 days after cerebral hemor- 
rhage had exacerbation of cerebral damage during 
the operation, 19.0% of 21 patients operated on 
more than 4 weeks later had an exacerbation. These 
data suggest that there is some risk of progression of 
cerebral damage 15 days and even 4 weeks after the 
hemorrhage, regardless of the timing of the opera- 
tion. The severity of cerebral complications and the 
ineffectiveness of antimicrobial therapy may affect 
cerebral damage, although this effect was not veri- 
fied statistically. The incidence of clinically apparent 
mycotic aneurysm in patients with bacterial endo- 
carditis was reported as 2% to 10%. 13-16' 19, 27, 28 In 
our study, a cerebral aneurysm was noticed in about 
80% of the patients with cerebral hemorrhage who 
received cerebral angiograms, and surgical treat- 
ment for cerebral aneurysm or hemorrhage would 
be expected to reduce the risk of cerebral damage 
during cardiac operations. To decrease the tendency 
toward hemorrhage, reduced heparinization i con- 
junction with a heparin-coated pump system would 
be useful during cardiac operations. 
Conclusion 
From a multi-center retrospective study, 181 pa- 
tients with infective endocarditis and cerebral com- 
plications were analyzed in detail. The rate of 
exacerbation of cerebral complications decreased to 
10% in patients who underwent surgical treatment 
more than 15 days after cerebral infarction and to 
2.3% in those operated on more than 4 weeks later. 
Preoperative risk factors were severity of cerebral 
complications, interval from onset of symptoms to 
operation, and uncontrolled heart failure as the 
indication for cardiac surgery. More than 15 days 
after cerebral hemorrhage, the risk of the progres- 
sion of cerebral damage is still significant, and this 
risk persists even 4 weeks later. 
We are grateful to all the institutions belonging to the 
JATS for providing data for this manuscript. 
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